Barclays’s Camtek CAMT Stock Holding History

Barclays’s Portfolio CAMT Stock Details CAMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$807K	Buy	+5,200	New	+$764K	﹤0.01%	3193

Other funds holding CAMT

Migdal Insurance & Financial Holdings Petach Tikva, Israel $16.3B AUM 54.64% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.8B AUM 42.86% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Y.D. More Investments Ramat Gan, Israel $3.47B AUM 82.09% 1-Year Est. Return

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Brown Capital Management Baltimore, Maryland $527M AUM 33.67% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Stephens Investment Management Group Houston, Texas $9.29B AUM 41.16% 1-Year Est. Return

Barclays's CAMT Position: Q3 2026 in Review

Barclays reduced its Camtek (CAMT) stake by 68% in Q3 2026, selling an estimated $1.42M and leaving 4,621 shares worth $717K. The position accounts for ﹤0.01% of the portfolio, ranked #3256.

Barclays first reported a position in CAMT in Q1 2017 and has held it in 25 quarters since. The position peaked at $2.34M in Q2 2026. 106 funds tracked by Wall St. Rank hold CAMT as of Q3 2026.

Barclays held 4,621 shares of Camtek worth $717K as of Q3 2026.
Barclays sold 9,697 Camtek shares in Q3 2026, an estimated $1.42M.
Camtek made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3256 holding.
Barclays first reported a position in Camtek in Q1 2017 and has held it in 25 quarters since.
Barclays's Camtek position peaked at $2.34M in Q2 2026.
106 funds tracked by Wall St. Rank held Camtek as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.